Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44])
The summary for the Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44]): -Purpose. This Funding Opportunity Announcement (FOA) encourages the translation of technologies for biomedical or behavioral research from academic and other non-small business research sectors to the marketplace. Small Business Concerns (SBCs) are encouraged to submit Small Business Innovation Research (SBIR) grant applications that propose to further develop, make more robust, and make more user-friendly such technologies in preparation for commercial dissemination. It is expected that this activity will require partnerships and close collaboration between the original developers of these technologies and SBCs, which may be accomplished in any of a number of ways, including the use of multiple principle investigators. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. This FOA runs in parallel with an FOA affiliated with the NIH Blueprint for Neuroscience Research, PA-08-071, Lab to Marketplace Tools for Brain and Behavioral Research. -Funds Available and Anticipated Number of Awards. For this FOA, Budgets up to $350,000 total costs per year and time periods up to 2 years for Phase I may be requested. Budgets up to $600,000 total costs per year and up to 3 years may be requested for Phase II. Phase II competing renewal budgets must be submitted in accordance with participating IC-specific budget limitations described in the SBIR Omnibus Solicitation Program Descriptions and Research Topics. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
|Federal Grant Title:||Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44])|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Health Food and Nutrition Education|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-08-114|
|Type of Funding:||Grant|
|CFDA Descriptions:||Human Genome Research 93.173 Research Related to Deafness and Communication Disorders|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||May 07, 2011|
|Posted Date:||Apr 09, 2008|
|Creation Date:||Apr 09, 2008|
|Archive Date:||Jan 27, 2009|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||93.213 -- Research and Training in Complementary and Alternative Medicine|
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...